​This service aims to assist Chinese biopharmaceutical companies in developing and implementing effective global clinical trial strategies. A team of experts composed of top Australian academicians, experienced clinical trial experts, and senior regulatory registration experts provides overall clinical development plans and R&D strategy guidance for Chinese companies entering overseas markets (especially startups) in global, Australian, and Chinese markets. This can help your company:​

• Develop an international clinical development strategy targeting unmet clinical needs and regulatory registration guidance. In the face of complex clinical and regulatory challenges, guide you to develop a clinical trial strategy that meets your company’s goals and regulatory requirements.​
• Establish international influence, enhance confidence, and open up a global perspective.​
• Help identify and mitigate potential risks, thereby reducing project costs and time risks.​
• Optimize clinical trial processes, improve efficiency, and accelerate product to the market.